The paradoxical role of IL-17 in atherosclerosis

Cell Immunol. 2015 Sep;297(1):33-9. doi: 10.1016/j.cellimm.2015.05.007. Epub 2015 May 29.

Abstract

Atherosclerosis is a chronic inflammatory disease mediated by innate and adaptive immune responses. In recent years, CD4(+) T cells (Th1, Th2, Treg, and Th17) have been increasingly studied for their role in atherosclerosis pathophysiology, atheroma stability, plaque rupture, and life-threatening acute coronary syndrome. IL-17, a marker cytokine of Th17 cells, has been reported to be involved in the pathogenesis of rheumatoid arthritis, inflammatory bowel disease, and asthma. However, its role in atherosclerosis has been poorly characterized. This article provides a comprehensive overview of the role of IL-17 in the development of atherosclerosis and human coronary artery diseases.

Keywords: Atherosclerosis; Coronary artery disease; IL-17; Immunity.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Atherosclerosis / immunology*
  • Coronary Artery Disease / immunology*
  • Disease Models, Animal
  • Humans
  • Inflammation / immunology
  • Interleukin-17 / immunology*
  • Mice
  • Th1 Cells / immunology
  • Th17 Cells / immunology*
  • Th2 Cells / immunology

Substances

  • IL17A protein, human
  • Interleukin-17